HIMS Amazon is starting to sell cheap hair-loss drugs. BofA downgraded the stock from Buy to Underperform. The stock reacted with a 25% drop.I had always been concerned about the threat from Amazon, along with legal and regulatory issues for this stock.
I don't think Amazon will stop at just selling hair-loss drugs. They might go for everything that Hims offers and more.
As for the technicals, today's drop is a huge blow to the momentum. If you are bullish on the company, I would wait for the bottoming process.
At a minimum, it could check back to the uptrend line.
See the potential drop area in the chart.
As always, I share my opinions and trades. I'm not suggesting that anyone follow my trades. You do you.
I am not a licensed professional. None of the posts that I published are investment advice. Do your own research.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
I am not a licensed professional. None of the posts that I published are investment advice. Do your own research.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。